# Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study

> **NCT00637065** · PHASE4 · UNKNOWN · sponsor: **Royal Brompton & Harefield NHS Foundation Trust** · enrollment: 48 (estimated)

## Conditions studied

- Pulmonary Hypertension
- Interstitial Lung Disease
- Idiopathic Pulmonary Fibrosis
- Nonspecific Interstitial Pneumonia

## Interventions

- **DRUG:** Bosentan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00637065
- **Lead sponsor:** Royal Brompton & Harefield NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-08
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2008-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00637065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00637065, "Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00637065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*